Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 3C4H4O6.2Bi.18H2O |
| Molecular Weight | 1186.4487 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Bi+3].[Bi+3].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O.O[C@H]([C@@H](O)C([O-])=O)C([O-])=O.O[C@H]([C@@H](O)C([O-])=O)C([O-])=O
InChI
InChIKey=KQGKVNJGGQFUNF-BHYHJUIYSA-H
InChI=1S/3C4H6O6.2Bi.18H2O/c3*5-1(3(7)8)2(6)4(9)10;;;;;;;;;;;;;;;;;;;;/h3*1-2,5-6H,(H,7,8)(H,9,10);;;18*1H2/q;;;2*+3;;;;;;;;;;;;;;;;;;/p-6/t3*1-,2-;;;;;;;;;;;;;;;;;;;;/m111..................../s1
| Molecular Formula | C4H6O6 |
| Molecular Weight | 150.0868 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | Bi |
| Molecular Weight | 208.9804 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.5 g 1 times / 2 weeks multiple, intravenous Studied dose Dose: 0.5 g, 1 times / 2 weeks Route: intravenous Route: multiple Dose: 0.5 g, 1 times / 2 weeks Sources: |
unhealthy, 39 years |
Other AEs: Nephrotic syndrome... |
650 mg 1 times / day single, intravenous Studied dose Dose: 650 mg, 1 times / day Route: intravenous Route: single Dose: 650 mg, 1 times / day Sources: |
unhealthy, adult |
Other AEs: Death... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Nephrotic syndrome | 0.5 g 1 times / 2 weeks multiple, intravenous Studied dose Dose: 0.5 g, 1 times / 2 weeks Route: intravenous Route: multiple Dose: 0.5 g, 1 times / 2 weeks Sources: |
unhealthy, 39 years |
|
| Death | 650 mg 1 times / day single, intravenous Studied dose Dose: 650 mg, 1 times / day Route: intravenous Route: single Dose: 650 mg, 1 times / day Sources: |
unhealthy, adult |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:01:22 GMT 2025
by
admin
on
Mon Mar 31 18:01:22 GMT 2025
|
| Record UNII |
K4X42T019U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 331.15
Created by
admin on Mon Mar 31 18:01:22 GMT 2025 , Edited by admin on Mon Mar 31 18:01:22 GMT 2025
|
||
|
CFR |
21 CFR 331.11
Created by
admin on Mon Mar 31 18:01:22 GMT 2025 , Edited by admin on Mon Mar 31 18:01:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C013848
Created by
admin on Mon Mar 31 18:01:22 GMT 2025 , Edited by admin on Mon Mar 31 18:01:22 GMT 2025
|
PRIMARY | |||
|
6591-69-1
Created by
admin on Mon Mar 31 18:01:22 GMT 2025 , Edited by admin on Mon Mar 31 18:01:22 GMT 2025
|
PRIMARY | |||
|
K4X42T019U
Created by
admin on Mon Mar 31 18:01:22 GMT 2025 , Edited by admin on Mon Mar 31 18:01:22 GMT 2025
|
PRIMARY | |||
|
71586900
Created by
admin on Mon Mar 31 18:01:22 GMT 2025 , Edited by admin on Mon Mar 31 18:01:22 GMT 2025
|
PRIMARY | |||
|
DTXSID80216147
Created by
admin on Mon Mar 31 18:01:22 GMT 2025 , Edited by admin on Mon Mar 31 18:01:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE |